Clearpoint Neuro Inc

NASDAQ CLPT

Data sourced from

and

Download Data

Clearpoint Neuro Inc Shareholders' Equity for the Trailing 12 Months (TTM) ending March 31, 2024: USD 34.58 M

Clearpoint Neuro Inc Shareholders' Equity is USD 34.58 M for the Trailing 12 Months (TTM) ending March 31, 2024, a 6.15% change year over year. Shareholders' Equity is the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Clearpoint Neuro Inc Shareholders' Equity for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 32.58 M, a -28.76% change year over year.
Clearpoint Neuro Inc Shareholders' Equity for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 45.73 M, a 3.97% change year over year.
Clearpoint Neuro Inc Shareholders' Equity for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 43.98 M, a 1,493.63% change year over year.
Clearpoint Neuro Inc Shareholders' Equity for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 2.76 M, a 82.65% change year over year.

NASDAQ: CLPT

Clearpoint Neuro Inc

CEO	Mr. Joseph Michael Burnett
IPO Date	Feb. 12, 2020
Location	United States
Headquarters	120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
Employees	107
Sector	Healthcare
Industry	Medical devices

Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Key trends